Evidence map›Paper›PMID 38213454›Full record

ArticleSurgical neurology international2023

Double pituitary neuroendocrine tumors in a patient with normal growth hormone level acromegaly: A case report and review of the literature.

Ichiro Nakazato, Kenichi Oyama, Hisashi Ishikawa, Yusuke Tabei, Chie Inomoto, Yoshiyuki Osamura, Akira Teramoto, Akira Matsuno

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Surgical neurology international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Ichiro NakazatoDepartment of Neurosurgery, International University of Health and Welfare Mita Hospital, Minato, Tokyo, Japan.
Kenichi OyamaDepartment of Neurosurgery, International University of Health and Welfare Mita Hospital, Minato, Tokyo, Japan.
Hisashi IshikawaDepartment of Neurosurgery, International University of Health and Welfare Mita Hospital, Minato, Tokyo, Japan.
Yusuke TabeiDepartment of Neurosurgery, International University of Health and Welfare Mita Hospital, Minato, Tokyo, Japan.
Chie InomotoDepartment of Pathology, Tokai University School of Medicine, Isehara, Japan.
Yoshiyuki OsamuraDivision of Pathology, Nippon Koukan Hospital, Kanagawa, Japan.
Akira TeramotoFaculty of Health Sciences, Shonan University of Medical Science, Kanagawa, Japan.
Akira MatsunoDepartment of Neurosurgery, International University of Health and Welfare Narita Hospital, Narita, Japan.
Mita Hospital · JPInternational University of Health and Welfare · JPNippon Koei (Japan) · JPShonan University of Medical Sciences · JPTokai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Acromegaly is a rare disease caused by growth hormone (GH) hypersecretion caused by a pituitary neuroendocrine tumor (PitNET). However, some acromegaly patients show normal GH levels, and they can be a pitfall in clinical diagnosis. Moreover, rarely, synchronous true double or multiple PitNETs are encountered. Moreover, these PitNETs increase the risk of a left lesion during surgical exploration. Case Description: The patient, who was a 73-year-old female, was referred to our hospital with a chief complaint of headache. Assessment of basal anterior pituitary function revealed a slightly high level of insulin-like growth factor-1 (IGF-1) (standard deviation, 2.4), and her physical findings exhibited mild acromegalic features. The endocrine evaluation confirmed acromegaly and magnetic resonance imaging (MRI) showed a macro PitNET with suprasellar extension. Endoscopic endonasal surgery (EES) was performed to remove the macro PitNET. Although postoperative MRI showed complete removal of the macro PitNET, endocrinological testing indicated no improvement in GH or IGF-1 excess. Pathological examination of the surgical specimen revealed a gonadotropic PitNET. Therefore, we repeated the MRI scan and found a micro PitNET in the thin left normal pituitary gland. A second EES was successfully performed to remove the micro PitNET completely, and both endocrinological and pathological examinations confirmed that the disease was cured. Conclusion: Diagnosing acromegaly with low GH levels requires close monitoring. Double PitNETs are relatively rare and can cause incomplete remission of functional PitNETs.

Indexed as

AcromegalyDouble pituitary neuroendocrine tumorEndoscopic endonasal surgeryPitNETPituitary

Identifiers

PMID38213454
PMCPMC10783686
OpenAlexW4389785724

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.